All Stories

  1. Serum mitochondrial DNA predicts the risk of acute exacerbation and progression of idiopathic pulmonary fibrosis

    Article • European Respiratory Journal, August 2020, European Respiratory Society (ERS)

    Koji Sakamoto, M.D., Ph.D. Taiki Furukawa

  2. Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2017, Dove Medical Press

    Koji Sakamoto, Naozumi Hashimoto